Bayer Sells $3.4 Billion Contraceptives Stake to Apollo

1 hour ago 4
The logo of Bayer AG.The logo of Bayer AG. Photo by Krisztian Bocsi /Bloomberg

Article content

(Bloomberg) — Bayer AG sold a minority stake in its contraceptives business to Apollo Global Management Inc. for €3 billion ($3.4 billion) and will use the funds raised to help cover its ballooning litigation costs tied to the herbicide Roundup. 

Financial Post

THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY

Subscribe now to read the latest news in your city and across Canada.

  • Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
  • Daily content from Financial Times, the world's leading global business publication.
  • Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
  • National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
  • Daily puzzles, including the New York Times Crossword.

SUBSCRIBE TO UNLOCK MORE ARTICLES

Subscribe now to read the latest news in your city and across Canada.

  • Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
  • Daily content from Financial Times, the world's leading global business publication.
  • Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
  • National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
  • Daily puzzles, including the New York Times Crossword.

REGISTER / SIGN IN TO UNLOCK MORE ARTICLES

Create an account or sign in to continue with your reading experience.

  • Access articles from across Canada with one account.
  • Share your thoughts and join the conversation in the comments.
  • Enjoy additional articles per month.
  • Get email updates from your favourite authors.

THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.

Create an account or sign in to continue with your reading experience.

  • Access articles from across Canada with one account
  • Share your thoughts and join the conversation in the comments
  • Enjoy additional articles per month
  • Get email updates from your favourite authors

Sign In or Create an Account

or

Article content

The German drugs-to-crop science conglomerate said Friday it will keep full operational control of the newly set up entity that sells long-acting reversible contraceptives to patients. This includes products like Mirena, a hormonal intrauterine device, which can provide up to eight years of contraception. Mirena, alongside other products Kyleena and Jaydess, generated about €1.4 billion in sales in 2025 for Bayer. 

Article content

Article content

Article content

The deal comes as Bayer Chief Executive Officer Bill Anderson is trying to turn around a company that has been weighed down by US litigation tied to its Roundup weedkiller. 

Article content

By signing up you consent to receive the above newsletter from Postmedia Network Inc.

Article content

In February, Bayer raised its litigation provisions to €11.8 billion. The company said at the time that immediate funding for the settlements and bond maturities was secured through an $8 billion bank-loan facility, while longer-term financing would come from other instruments. The sale is part of that broader plan to manage its litigation costs. 

Article content

Bayer last week also moved to separate its US glyphosate business, which includes the herbicide, into a separate business unit after a favorable Supreme Court ruling on the litigation.

Article content

Shares of Bayer rose as much as 2% on Friday. The stock has risen about 40% so far this year. 

Article content

For Apollo, the Bayer deal is the latest in a series of private capital financings the New York-listed asset manager has struck with blue-chip companies. Over the years, the firm has spearheaded some of the industry’s most complex multibillion-dollar transactions, striking deals with corporates including Intel Corp., Electricité de France SA, and Vonovia SE. 

Article content

Article content

Earlier this year, Apollo also led a $35 billion financing package for Anthropic PBC to expand its AI infrastructure.

Article content

Apollo has increasingly identified Europe as a key growth market. Last year, President Jim Zelter said the firm could deploy as much as $100 billion in financing across Germany alone over the next decade.

Article content

The firm has already established a substantial footprint in the region through a series of investments in European energy infrastructure, including a $6.5 billion commitment to Ørsted’s offshore wind project in the UK and a €3.2 billion investment in RWE’s German power grid business.

Article content

On Friday, in a separate development, Apollo also made an offer for EasyJet Plc that beats a rival proposal from Castlelake, a surprise twist in the takeover battle for the UK budget carrier that sets up a possible competition between the two US investment funds. 

Article content

—With assistance from Silas Brown.

Article content

(Updates with context and shares starting from second paragraph.)

Article content

Read Entire Article